P2-2 Impact of maternal connective tissue disease on conduction abnormalities in the offspring
Sarah Sofie Andersen
P2-3 Impact of cardiac devices on Quality of Life
Paolo Gatti
P2-4 Reduced liver fat and improved cardiometabolic health in individuals with non alcoholic fatty liver disease after a 12 week digital health program - a feasibility study
Sigríður Björnsdóttir
P2-5 Myocardial stunning model in rats
Ahmed Elmahdy
Poster session 3 - Imaging / Basic science
P3-2 Valvular Keloids? Aggressive Scarring Process Leading to Multivalvular Obstruction
Nikhil Kolluri
P3-3 Non-invasive assessments reveal that > 50 % of newly diagnosed asymptomatic patients with type-2 diabetes mellitus have subclinical atherosclerosis.
Gulia Faizi
P3-4 Incidence rates of cardiovascular disease in Greenland 1994 - 2020
Hjalte Erichsen Larsen
15:00 - 15:30
Poster session 4 - Coronary artery disease
P4-1 A digital health program is feasible for outpatient care in coronary artery disease
Davíð Ottó Arnar
P4-2 Online cognitive behavioral therapy targeting cardiac anxiety following myocardial infarction: rational and design of a randomized control trial
Amanda Johnsson
P4-3 Early changes in myocardial stunning and biomarkers after ST-elevation myocardial infarction compared to the takotsubo syndrome
Ahmed Elmahdy
P4-4 Beating Heart CABG on Intermittent Pump Support
Sushil Kumar Singh
P4-5 Decoding the Impact of SIRT1 Gene Variants in Coronary Microvascular Dysfunction following ST-Elevation Myocardial Infarction
Benas Kireilis
P4-6 “The future of coronary artery revascularization with bioresorbable stents”
Andrejs Erglis
Poster session 5 - Heart failure
P5-1 Impact of the COVID-19 pandemic on the incidence and mortality in takotsubo syndrome: a report from Swedish Coronary Angiography and Angioplasty Registry
Elmir Omerovic
P5-2 Importance of hospital and clinical factors in predicting of 30-day mortality in Takotsubo syndrome: Data from the Swedish Coronary Angiography and Angioplasty Registry
Elmir Omerovic
P5-3 Pre-implantation central hemodynamic profile of HFrEF patients receiving CRT or ICD: a two-centre controlled study
Anette Caroline Kõre
P5-4 Study of novel immunomarkers’ expression in left ventricular cardiomyocytes during remodeling in progressing heart failure (HF) of ischemic origin
Milda Kupryte
Poster session 6 - Hypertension
P6-1 Influence of nebivolol, bisoprolol and carvedilol on the penile hemodynamic in men with arterial hypertension
Gulnara Nur-Mammadova
P6-3 Prevalence of apparent treatment-resistant hypertension in Iceland and adherence to clinical practice guidelines
Kristján Harðarson
Time
Friday, June 9
10:00 - 10:30
Poster session 7 - Interventional cardiology and cardiovascular surgery
P7-1 Carotid artery stenting in a patient with high platelet reactivity due to hematologic neoplasm. A case report.
Kristina Lotamõis
P7-2 Long-term outcome after venosus-type atrial septal defect closure
Valtteri Juho Matias Muroke
P7-3 Intrahospital outcomes of true coronary bifurcation treatment. Latvian Center of Cardiology.
Eva Bolsteina
P7-4 Indications and outcomes of TAVI (transcatheter aortic valve implantation) in Iceland
Ingibjörg Guðmundsdóttir
P7-5 Percutaneous coronary intervention post transcatheter aortic valve implantation
Monér Alchay
P7-6 “One-year clinical outcomes of sirolimus-eluting bioresorbable stent implantation. Single centre real-life registry data for N=333 patients”
Andrejs Erglis
Poster session 8 - Myocardial, pericardial and valvular disease
P8-1 Myocarditis: risk factors for longer hospitalization during Covid-19 pandemic
Monika Biesevičienė
P8-2 Prognostic role of atrial fibrillation in patients with non-compaction cardiomyopathy
Nadiia Rineiska
P8-3 Leaflet mechanical stress distribution in different designs of surgical and transcatheter aortic valve bioprostheses: An in vitro study
Regis RIEU
P8-4 Left ventricular strain on ECG in patients with severe aortic stenosis undergoing Transcatheter Aortic Valve Implantation (TAVI); Insights from TAVI-NOR study
Daanyaal Wasim
P8-5 Earlier detection of significant perioperative myocardial injury after cardiac surgery
Zineb Chaabi
P8-6 Left ventricular non-compaction in childhood: echocardiographic follow-up and prevalence in first-degree relatives
Thilde Olivia Kock
15:00 - 15:30
Poster session 9 - Other I
P9-1 Heart Rhythm Control in Children and Adolescents with Psychiatric Disorders: A Pilot Study on Heart Rate Variability and Medication Use
Kamile Plesnyte Capkauskiene
P9-2 Cost analysis of treating cardiovascular diseases in a superspeciality hospital in India
Vijaydeep Siddharth
P9-3 Association between pre-operative prolonged corrected QT interval and all-cause mortality after non-cardiac surgery
Helena Xiang Jóhannsdóttir
P9-4 Autopsy findings of sudden cardiac death victims at premenopausal and postmenopausal age
Mira Anette Emilia Eskuri
P9-5 Increased Cyber Vulnerability and Need for Cyber Risk Transparency in the Informed Consent for Patients with Cardiac Implantable Electronic Devices
Leanne N.S. Torgersen
P9-6 Complex trust-building process as part of the use of technology in digital cardiac rehabilitation
Marjo-Riitta Anttila
Poster session 10 - Other II
P10-1 Impact of prior use of anthracyclines on cardiac function in patients before undergoing hematopoietic stem cell transplantation
Audrone Vaitiekiene
P10-2 The results of a 10-year longitudinal monitoring of cardiac rehabilitation patients
Maie Ojamaa
P10-3 Chronic pain after lung transplantation A nationwide study – short and long term
Jytte Graarup
P10-4 Health Self-Assessment and Cardiovascular Risk Factors in Population of Latvia. Cross-sectional study
Iveta Bajare
P10-5 Case report: Atypical developmental delay associated with Ebstein anomaly following early hypoxia or comorbidity
Loriana Kilaitė
P10-6 An acquired fistula between coronary and pulmonary arteries after heart transplantation
Anna Maria Punab
Poster session 11 - Preventive cardiology
P11-1 Oral anticoagulant use by lifeday coverage and one-year relative survival in atrial fibrillation patients in Estonia 2019 and 2020
Priit Pauklin
P11-2 Peripheral bioimpedance curves – just a heart in a magic mirror or crystal ball for cardiovascular prevention
Kristina Lotamõis
P11-3 Expanding access to cardiac rehabilitation: a remote service model for heart disease patients
Mattias Tralla
P11-4 Is statin lipid-lowering therapy sufficient for LDL-C goal attainment in very high cardiovascular risk Lithuanians?
Jolita Badariene
P11-5 Non-participants in cardiac rehabilitation; -why 47% don´t participate in cardiac rehabilitation
Nanna Nørgaard Eg
Congress secretariat
Athygli Conferences Armula 11 108 Reykjavík Iceland